- Home
- HCWB vs CVR Comparison
HCWB vs CVR Comparison
Compare HCWB & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- CVR
- Stock Information
- Founded
- HCWB 2018
- CVR 1920
- Country
- HCWB United States
- CVR United States
- Employees
- HCWB N/A
- CVR N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- CVR Industrial Machinery/Components
- Sector
- HCWB Health Care
- CVR Industrials
- Exchange
- HCWB Nasdaq
- CVR Nasdaq
- Market Cap
- HCWB 10.8M
- CVR 11.1M
- IPO Year
- HCWB 2021
- CVR N/A
- Fundamental
- Price
- HCWB $4.31
- CVR $11.94
- Analyst Decision
- HCWB Strong Buy
- CVR
- Analyst Count
- HCWB 1
- CVR 0
- Target Price
- HCWB $35.00
- CVR N/A
- AVG Volume (30 Days)
- HCWB 112.9K
- CVR 2.0K
- Earning Date
- HCWB 08-13-2025
- CVR 08-15-2025
- Dividend Yield
- HCWB N/A
- CVR 1.05%
- EPS Growth
- HCWB N/A
- CVR N/A
- EPS
- HCWB N/A
- CVR N/A
- Revenue
- HCWB $1,445,145.00
- CVR $26,379,081.00
- Revenue This Year
- HCWB $178.36
- CVR N/A
- Revenue Next Year
- HCWB N/A
- CVR N/A
- P/E Ratio
- HCWB N/A
- CVR N/A
- Revenue Growth
- HCWB N/A
- CVR N/A
- 52 Week Low
- HCWB $3.55
- CVR $8.15
- 52 Week High
- HCWB $100.80
- CVR $22.27
- Technical
- Relative Strength Index (RSI)
- HCWB 39.51
- CVR 43.20
- Support Level
- HCWB $4.02
- CVR $12.45
- Resistance Level
- HCWB $4.44
- CVR $13.25
- Average True Range (ATR)
- HCWB 0.31
- CVR 0.32
- MACD
- HCWB 0.06
- CVR 0.04
- Stochastic Oscillator
- HCWB 11.95
- CVR 38.21
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.